Saturday , November 16 2024

The matter of side effects of Corona vaccine Covishield reached the Supreme Court, demand for compensation raised

Global pharmaceutical AstraZeneca has admitted that the Covid-19 vaccine developed by Oxford University researchers may have side effects. This can cause blood clotting. AstraZeneca has admitted the harm of the vaccine in the UK High Court. After this there has been a stir. This vaccine has been introduced in India under the name of Covishield. Now an application has been filed in the Supreme Court regarding this matter and a demand has been made to issue instructions in the interest of public health safety.

In the application, a demand has been raised to include all India experts in the medical expert panel. Advocate Vishal Tiwari has requested the Supreme Court to take action on the basis of AstraZeneca's confession in the petition pending since 2021. It has been said in the application that a committee should be formed under the chairmanship of a retired judge of the Supreme Court to investigate the side effects of Covishield.

The application states that the committee should include the director and experts of AIIMS, Institute of Medical Sciences, Delhi as members. The central government has been asked to issue instructions to investigate the side effects of the vaccine and determine the risks and harms. Apart from this, provision should be made for compensation payment to the victimized citizens. It has been demanded that instructions should be issued to provide compensation to those who became seriously disabled or died due to the adverse effects of the Corona vaccine.

In India, Covishield has been developed at the Serum Institute of Pune. 175 crore doses have been given. AstraZeneca has acknowledged in a UK court the side effects of thrombosis including thrombocytopenia syndrome (TTS). There have been allegations of serious harm and death due to this vaccine, the case of which is going on in the High Court of Britain. The cases emerged within months of the start of vaccination campaigns in Europe, prompting some countries to temporarily ban the use of the AstraZeneca vaccine.